Diagnostics News and Research

RSS

Glycan released by parasites might help treat metabolic disorders associated with obesity

On the list of undesirable medical conditions, a parasitic worm infection surely ranks fairly high. Although modern pharmaceuticals have made them less of a threat in some areas, these organisms are still a major cause of disease and disability throughout much of the developing world.

9 Jan 2013

Debiopharm, Spinomix announce closing of Series A equity financing

Debiopharm Group (Debiopharm) and Spinomix SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a Series A equity investment of $ 3 Million.

9 Jan 2013

Researchers use electrokinetic patterning to separate particles and microbes by size

Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.

9 Jan 2013

Genomic and cellular solutions to be featured by Beckman Coulter Life Sciences at SLAS2013

Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme.

From Beckman Coulter Life Sciences - Automation and Genomics 8 Jan 2013

Seven scientists named 2013 recipients of Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that seven scientists with novel approaches to fighting cancer have been named 2013 recipients of the Damon Runyon-Rachleff Innovation Award.

8 Jan 2013

FDA approves Abbott’s XIENCE Xpedition Everolimus Eluting Coronary Stent System

Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U.S. market.

3 Jan 2013

Trovagene, MD Anderson partner to detect transrenal BRAF mutations in metastatic cancers

Trovagene, Inc., a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF mutations in the urine of patients with advanced or metastatic cancers.

3 Jan 2013

UMDNJ-School of Osteopathic Medicine establishes Biomarker Discovery Center

Following recent discoveries by its researchers that could significantly change the diagnosis and treatment of a number of diseases, the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine has established the Biomarker Discovery Center on its Stratford campus.

3 Jan 2013

EPIRUS’ BOW-015 achieves bioequivalence to Remicade in a single dose comparator trial

EPIRUS Biopharmaceuticals, Inc., formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade in a single dose comparator trial.

3 Jan 2013

FDA clears Cepheid Xpert CT/NG molecular diagnostic test

Cepheid today announced that it has received clearance from the U.S. Food & Drug Administration to market Xpert CT/NG. Running on Cepheid's GeneXpert Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae. For the first time, same-day patient consultation and treatment is possible for the two most common sexually transmitted bacterial infections in the United States.

28 Dec 2012

Trovagene adds Duke University Health System to worldwide licensees of NPM1 marker for AML

Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).

27 Dec 2012

Use of CT scans for children suspected of having appendicitis varies among hospitals

Children suspected of having appendicitis are more likely to receive CT scans, which involve radiation, if they are evaluated at a general hospital, a new study by Washington University School of Medicine in St. Louis has shown.

25 Dec 2012

Parkinson’s: an interview with Steve Ford, CEO of Parkinson’s UK

Parkinson’s disease is a neurological condition that is caused when brain cells, that produce the chemical messenger dopamine, start to die.

24 Dec 2012

Roche, PSS partner to develop fully automated emulsion PCR instrument for sequencing

Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.

From Roche Sequencing and Life Science 21 Dec 2012

Novel way to design metal organic frameworks under completely liquid-free conditions

Researchers at Aldrich Materials Science, a strategic technology initiative of Sigma-Aldrich Corporation have discovered an innovative way to design an important class of three-dimensional (3D) hybrid structures, Metal Organic Frameworks (MOFs), under completely liquid-free conditions.

20 Dec 2012

Maneuvering toward a 'fiscal cliff' deal

Despite progress toward an agreement with the White House, House Republicans appeared to veer off course Tuesday with a "Plan B" if budget talks fail. Some media outlets suggested that both President Barack Obama and Speaker John Boehner, R-Ohio, are attempting to quell backlash within their own parties -- Boehner for agreeing to tax increases, Obama for ceding some entitlement cuts.

20 Dec 2012

Investigators report non-coding miRNAs as appealing biomarkers for cancer malignancy

As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new issue of Cancer Biomarkers, investigators report on non-coding miRNAs as appealing biomarkers for malignancy.

20 Dec 2012

Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector

The University of Texas at Arlington and Thermo Fisher Scientific Inc., the world leader in serving science, announced that they have been granted a United States patent (#8,293,099) for a novel charge detector for ion chromatography that they developed together.

From Thermo Fisher Scientific Inc. 20 Dec 2012

Continued U.S. leadership crucial to building on global progress against TB

Tuberculosis (TB) "is the second leading cause of death due to infectious disease worldwide; taking approximately 1.4 million lives in 2011 alone," Rep. Eliot Engel (D-N.Y.), a co-chair of the TB Elimination Caucus, writes in an opinion piece in The Hill's "Congress Blog".

19 Dec 2012

HAL Allergy completes enrollment in SUBLIVAC FIX Phleum pratense Phase II trial

HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II trial with SUBLIVAC FIX Phleum pratense.

19 Dec 2012

Diagnostics News and Research

Glycan released by parasites might help treat metabolic disorders associated with obesity

Debiopharm, Spinomix announce closing of Series A equity financing

Researchers use electrokinetic patterning to separate particles and microbes by size

Genomic and cellular solutions to be featured by Beckman Coulter Life Sciences at SLAS2013

Seven scientists named 2013 recipients of Damon Runyon-Rachleff Innovation Award

FDA approves Abbott’s XIENCE Xpedition Everolimus Eluting Coronary Stent System

Trovagene, MD Anderson partner to detect transrenal BRAF mutations in metastatic cancers

UMDNJ-School of Osteopathic Medicine establishes Biomarker Discovery Center

EPIRUS’ BOW-015 achieves bioequivalence to Remicade in a single dose comparator trial

FDA clears Cepheid Xpert CT/NG molecular diagnostic test

Trovagene adds Duke University Health System to worldwide licensees of NPM1 marker for AML

Use of CT scans for children suspected of having appendicitis varies among hospitals

Parkinson’s: an interview with Steve Ford, CEO of Parkinson’s UK

Roche, PSS partner to develop fully automated emulsion PCR instrument for sequencing

Novel way to design metal organic frameworks under completely liquid-free conditions

Maneuvering toward a 'fiscal cliff' deal

Investigators report non-coding miRNAs as appealing biomarkers for cancer malignancy

Thermo Scientific, UT Arlington receive U.S. patent for Dionex QD detector

Continued U.S. leadership crucial to building on global progress against TB

HAL Allergy completes enrollment in SUBLIVAC FIX Phleum pratense Phase II trial

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News